The tRNAVal half: A strong endogenous Toll-like receptor 7 ligand with a 5′-terminal universal sequence signature
Article in Proceedings of the National Academy of Sciences of the United States of America (April 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
NLRP2 in health and disease
Article in Immunology (September 2023)
New small molecules in dermatology: for the autoimmunity, inflammation and beyond
Article in Inflammation Research (May 2023)